Clinical features and risk factors for gout attacks during anti‐tuberculosis treatment: A case‐control study in South Korea-Reference-Cited by-同舟云学术

Clinical features and risk factors for gout attacks during anti‐tuberculosis treatment: A case‐control study in South Korea

Published:2019-09-17 Issue:10 Volume:22 Page:1905-1911
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J Rheum Dis

Author:

Ha You‐Jung¹^ORCID,Chung Sang Wan¹,Lee Jae Hyun²^ORCID,Kang Eun Ha¹,Lee Yun Jong¹³,Song Yeong Wook²³⁴^ORCID

Affiliation:

1. Division of Rheumatology Department of Internal Medicine Seoul National University Bundang Hospital Seongnam Korea

2. Division of Rheumatology Department of Internal Medicine Seoul National University Hospital Seoul Korea

3. Department of Internal Medicine Seoul National University College of Medicine Seoul Korea

4. Department of Molecular Medicine and Biopharmaceutical Sciences Graduate School of Convergence Science and Technology and College of Medicine Medical Research Center Seoul National University Seoul Korea

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1756-185X.13697

Reference35 articles.

1. Diagnosis and management of gout

2. Gout and the risk of acute myocardial infarction

3. Global epidemiology of gout: prevalence, incidence and risk factors

4. Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008

5. The Prevalence and Features of Korean Gout Patients Using the National Health Insurance Corporation Database

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlations among the plasma concentrations of first-line anti-tuberculosis drugs and the physiological parameters influencing concentrations;Frontiers in Pharmacology;2023-10-06

2. Lowering and Raising Serum Urate Levels: Off-Label Effects of Commonly Used Medications;Mayo Clinic Proceedings;2022-07

3. Host‐directed anti‐mycobacterial activity of colchicine, an anti‐gout drug, via strengthened host innate resistance reinforced by the IL‐1β/PGE ₂ axis;British Journal of Pharmacology;2022-04-07

4. Analysis of influencing factors on the plasma concentration of first-line anti-tuberculosis drugs-a single-center retrospective cohort study;Annals of Translational Medicine;2022-04

5. Differential Diagnosis of Inflammatory Arthropathy Accompanying Active Tuberculosis Infection;Journal of Rheumatic Diseases;2022-04-01